Biotech Candidates

Update

Biotech Candidates

Biotech Candidates — March 31, 2026

Overview

Biotech broadly weakening. LLY gave back the "near entry" thesis — RSI dropped from 31.8 to 40.9 (a bounce) but price now -3.2% below SMA20. MRNA reversed sharply: RSI 57 → 48.5, -6.4% 7D, trend still shows strong-up but losing momentum. BIIB weakened from RSI 57 to 43.2, -3.2% below SMA20 — the quiet strong-up thesis is cooling. TMO RSI 46.8, flat on week — life sciences tools not breaking out. CRSP falling further. NTLA slipping: RSI 51 → 49.3, -9.7% 7D. VRTX RSI 42.8 stable but below SMA20.

Candidates

Ticker Price RSI Trend 7D 30D Signal Take
LLY $916.02 40.9 weak-down -1.6% -10.0% GC GLP-1 giant. RSI bounced from 31.8 but weak-down now. -3.2% vs SMA20. Watch $900.
MRNA $50.07 48.5 strong-up -6.4% -5.3% GC mRNA momentum cooling. Still strong-up trend. -5.3% vs SMA20. Hold but watch.
TMO $489.11 46.8 down -0.6% -3.7% GC Life sciences tools flat. +0.7% vs SMA20. Down trend. Wait for reversal.
VRTX $445.47 42.8 weak-down -0.8% -8.4% GC Pain franchise stable. -3.3% vs SMA20. Above SMA200.
BIIB $179.67 43.2 weak-down +1.9% -4.5% GC Lost strong-up signal. -3.2% vs SMA20. Watch RSI 40.
NTLA $12.81 49.3 weak-down -9.7% -17.0% GC In-vivo gene editing selling off. Lost strong-up signal. -2.1% vs SMA20.
CRSP $46.96 42.9 strong-down -3.9% -22.7% DC Gene editing broken. Death cross. -5.8% below SMA20. Avoid.

Action Items

  • LLY: RSI bounced from oversold to 40.9 but now in weak-down. Below SMA20. The entry zone (RSI < 30) is gone for now. Watch $900 as next test level.
  • MRNA: Strong-up trend intact despite -6.4% week. Position holder — don't add aggressively until RSI stabilizes above 50.
  • BIIB: Lost the "under-the-radar strong-up" signal. Monitor RSI 40 for re-entry thesis.
  • NTLA: -9.7% 7D and -17% 30D is deterioration — lost strong-up signal. No longer a buy.
  • CRSP: Avoid. Death cross + -22.7% 30D = no floor.

Key Changes vs 03/26

Ticker Price 03/26 Price 03/31 Move Note
LLY $896.61 $916.02 +2.2% Price up but trend flipped to weak-down from oversold bounce
MRNA $53.57 $50.07 -6.5% Strong-up trend but momentum cooling sharply
BIIB $191.06 $179.67 -6.0% Lost strong-up signal. RSI 57 → 43.
TMO $488.85 $489.11 +0.0% Basically flat. No +6.9% follow-through from 03/26.
NTLA $13.24 $12.81 -3.2% Lost strong-up. -9.7% 7D.
CRSP $47.55 $46.96 -1.2% Continued deterioration. Death cross holds.
10 events
DateTypeEvent
Mar 31 ScanBiotech Scan Mar 26 UpdateBiotech Candidates Mar 26 ScanBiotech Scan Mar 24 ScanBiotech Scan Mar 20 ScanBiotech Scan Mar 13 ScanBiotech Scan Apr 3 UpdateBiotech Candidates Apr 3 ScanBiotech Scan Mar 12 UpdateBiotech Mar 12 ScanBiotech Scan

No direct external sources are attached to this read.